Target intelligence / Profile preview

Host enterocyte cell-surface glycan

Molecular classification
Glycan, Carbohydrate, Receptor
01

Overview

Host enterocyte cell-surface glycan refers to the diverse array of complex carbohydrate structures, including glycoproteins and glycolipids, found on the apical surface of intestinal epithelial cells (enterocytes). These glycans are essential for maintaining the intestinal mucosal barrier and facilitating critical cell-cell communication and recognition processes (Bode, 2012, Glycobiology). However, they also serve as primary attachment factors or receptors for a wide range of enteric pathogens, including Norovirus, Rotavirus, and bacterial toxins like the cholera toxin (Tan & Jiang, 2014, Nature Reviews Microbiology). For example, the expression of specific histo-blood group antigens (HBGAs) on the enterocyte surface determines an individual's susceptibility to certain Norovirus strains, a trait linked to the FUT2 secretor status (McGovern et al., 2010, Nature Genetics). Therapeutic interventions targeting these glycans typically employ glycan mimetics or soluble decoy receptors, such as human milk oligosaccharides (HMOs), to competitively inhibit pathogen binding and prevent infection (Hu et al., 2012, Nature). While promising, these strategies must account for the potential disruption of the host's commensal microbiota, which also interacts with these glycan structures. Overall, the study of enterocyte glycans is vital for developing novel anti-infective agents and understanding the genetic basis of host-pathogen interactions in the gut.

Other names
Intestinal glycansEnterocyte glycoconjugatesCell-surface carbohydratesHisto-blood group antigensHBGAsSialylated glycansMucosal glycans
02

Mechanism of action

Competitive inhibition of pathogen adhesion by acting as decoy receptors or blocking binding sites on the host cell surface.

03

Biological functions

Cell-cell recognitionPathogen attachmentMucosal barrier maintenanceCell signalingCell-matrix interaction
04

Disease associations

InfectionGastroenteritisInflammatory bowel diseaseMalabsorption
05

Safety considerations

Disruption of commensal microbiotaPotential interference with normal mucosal signalingOff-target effects on systemic glycansDisruption of mucosal barrier integrity
06

Interacting drugs

2'-Fucosyllactose

4 more in the full profile.

07

Biomarkers

FUT2 genotype (Secretor status)Lewis blood group statusGlycan expression profiling

Beyond the preview

Go deeper on Host enterocyte cell-surface glycan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host enterocyte cell-surface glycan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call